TPH2 and metabolic disease: Taken together, future studies are needed to further investigate the possible interactions and clinical relevance between hyperinsulinemia-induced adipocyte TPH2 expression, circulating levels of 5-HT, and their effects on systemic metabolism and metabolic disorders.